---
figid: PMC12251215__jcm-14-04805-g002
figtitle: 'Wnt Signaling Pathways: canonical (Wnt/Beta-catenin) and non-canonical
  (Wnt/planar cell polarity, PCP and Wnt/Ca2+) pathways'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12251215
filename: jcm-14-04805-g002.jpg
figlink: /pmc/articles/PMC12251215/figure/F2/
number: F2
caption: 'Overview of Wnt Signaling Pathways: canonical (Wnt/β-catenin) and non-canonical
  (Wnt/planar cell polarity, PCP and Wnt/Ca2+) pathways. In the absence of Wnt ligands,
  β-catenin is phosphorylated by the destruction complex, which consists of Axin,
  adenomatous polyposis coli (APC), glycogen synthase kinase 3β (GSK3β), and casein
  kinase 1α (CK1α). Phosphorylated β-catenin is recognized by β-transducin repeat-containing
  proteins (β-TrCP), ubiquitinated and targeted for proteasomal degradation. As a
  result, Wnt target genes are repressed by TCF/LEF transcription factors complexed
  with corepressors such as TLE/Groucho. Upon Wnt ligand binding to Frizzled receptors
  and LRP5/6 co-receptors, LRP phosphorylation promotes the recruitment of Disheveled
  (DVL) to the plasma membrane. Activated DVL disrupts the destruction complex, preventing
  β-catenin degradation. Stabilized β-catenin accumulates in the cytoplasm and translocates
  into the nucleus, where it displaces TLE/Groucho from TCF/LEF, forming an active
  transcriptional complex. This complex, assisted by co-activators, including CBP/p300,
  BCL9, Pygo, and BRG1, induces the expression of Wnt target genes. Noncanonical Wnt
  signaling (Wnt/PCP and Wnt/Ca2+) activates DVL-associated activator of morphogenesis
  1 (Daam1), RhoA–Rho-associated kinase (ROCK), and Rac1–c-Jun N-terminal kinase (JNK),
  inducing cytoskeletal remodeling. The Wnt/Ca2+ pathway signals via phospholipase
  C, diacylglycerol (DAG), inositol trisphosphate (IP3), and Ca2+, which inhibits
  cyclic guanosine monophosphate (cGMP) while activating protein kinase C (PKC), calmodulin-dependent
  kinase II (CaMKII), nuclear factor of activated T cells (NFAT), cyclic AMP response
  element-binding (CREB) protein, nuclear factor kappa B (NF-κB), and activator protein
  1 (AP-1)'
papertitle: 'Wnt Signaling and Circular RNAs in Esophageal and Gastric Cancers: Opportunities
  for Early Detection and Targeted Therapy'
reftext: Piotr Paweł Chmielewski, et al. J Clin Med. 2025 Jul;14(13).
year: '2025'
doi: 10.3390/jcm14134805
journal_title: Journal of Clinical Medicine
journal_nlm_ta: J Clin Med
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: circular RNAs (circRNAs) | esophageal and gastric cancer | gastrointestinal
  cancers | liquid biopsy biomarkers | oncogenic signaling networks | Wnt signaling
  | precision oncology
automl_pathway: 0.9499642
figid_alias: PMC12251215__F2
figtype: Figure
redirect_from: /figures/PMC12251215__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12251215__jcm-14-04805-g002.html
  '@type': Dataset
  description: 'Overview of Wnt Signaling Pathways: canonical (Wnt/β-catenin) and
    non-canonical (Wnt/planar cell polarity, PCP and Wnt/Ca2+) pathways. In the absence
    of Wnt ligands, β-catenin is phosphorylated by the destruction complex, which
    consists of Axin, adenomatous polyposis coli (APC), glycogen synthase kinase 3β
    (GSK3β), and casein kinase 1α (CK1α). Phosphorylated β-catenin is recognized by
    β-transducin repeat-containing proteins (β-TrCP), ubiquitinated and targeted for
    proteasomal degradation. As a result, Wnt target genes are repressed by TCF/LEF
    transcription factors complexed with corepressors such as TLE/Groucho. Upon Wnt
    ligand binding to Frizzled receptors and LRP5/6 co-receptors, LRP phosphorylation
    promotes the recruitment of Disheveled (DVL) to the plasma membrane. Activated
    DVL disrupts the destruction complex, preventing β-catenin degradation. Stabilized
    β-catenin accumulates in the cytoplasm and translocates into the nucleus, where
    it displaces TLE/Groucho from TCF/LEF, forming an active transcriptional complex.
    This complex, assisted by co-activators, including CBP/p300, BCL9, Pygo, and BRG1,
    induces the expression of Wnt target genes. Noncanonical Wnt signaling (Wnt/PCP
    and Wnt/Ca2+) activates DVL-associated activator of morphogenesis 1 (Daam1), RhoA–Rho-associated
    kinase (ROCK), and Rac1–c-Jun N-terminal kinase (JNK), inducing cytoskeletal remodeling.
    The Wnt/Ca2+ pathway signals via phospholipase C, diacylglycerol (DAG), inositol
    trisphosphate (IP3), and Ca2+, which inhibits cyclic guanosine monophosphate (cGMP)
    while activating protein kinase C (PKC), calmodulin-dependent kinase II (CaMKII),
    nuclear factor of activated T cells (NFAT), cyclic AMP response element-binding
    (CREB) protein, nuclear factor kappa B (NF-κB), and activator protein 1 (AP-1)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GSK3A
  - GSK3B
  - APC
  - PROC
  - YAP1
  - TAFAZZIN
  - WWTR1
  - BTRC
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LRP5
  - LRP6
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - BMP1
  - PRCP
  - PGPEP1
  - ROR2
  - RORA
  - ROR1
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - CSNK1A1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - RAC1
  - RNASE1
  - DAAM1
  - CTNNB1
  - RHOA
  - AXIN1
  - AXIN2
  - MAPK8
  - MAPK9
  - MAPK10
  - ROCK1
  - ROCK2
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CAMK2G
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - HNF4A
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - SMARCA4
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - NFKB1
  - JUN
  - FOS
  - FOSB
  - JUNB
  - JUND
  - CGMP
  - Nucleus
---
